CRISPR Therapeutics AGCRSPNASDAQ
Loading
Net Margin Over TimeContracting
Percentile Rank20
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-22215.39%
Near historical average
Percentile
P20
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-22677.96%
Historical baseline
PeriodValueYoY Change
TTM-22215.39%-2023.0%
2024-1046.43%-2420.5%
2023-41.52%+100.0%
2022-149122.71%-360637.9%
202141.36%+100.1%
2020-48520.86%-210264.2%
201923.09%+100.4%
2018-5281.08%-3067.3%
2017-166.74%+62.9%
2016-449.30%-